Stephan Kontos
Director/Board Member at Aperiam Bio, Inc.
Profile
Stephan is an Entrepreneur-in-Residence based in Versant’s San Francisco office.
He brings deep operational and international business experience in early stage companies, as well as expertise in immunology and protein engineering to new company creation.
Prior to joining Versant, Stephan was Chief Scientific Officer of Anokion, a company he co-founded based on work from his doctoral thesis.
At Anokion, he defined and led R&D efforts to achieve successful human translation of a novel immune-based platform technology to treat autoimmune diseases.
Stephan holds a BSc in Chemical Engineering from the University of Texas and a Ph.D.
in Bioengineering from the Swiss Federal Institute of Technology in Lausanne.
Stephan Kontos active positions
| Companies | Position | Start |
|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Private Equity Investor | 01/10/2022 |
Aperiam Bio, Inc.
 Aperiam Bio, Inc. BiotechnologyHealth Technology Aperiam Bio, Inc. is a biotechnology company that develops skincare products. The company is based in Austin, TX. The CEO of the company is Cole Austin. | Director/Board Member | 01/03/2022 |
Former positions of Stephan Kontos
| Companies | Position | End |
|---|---|---|
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Founder | 01/10/2022 |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Founder | - |
Training of Stephan Kontos
| The University of Texas at Austin | Undergraduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Aperiam Bio, Inc.
Aperiam Bio, Inc. BiotechnologyHealth Technology Aperiam Bio, Inc. is a biotechnology company that develops skincare products. The company is based in Austin, TX. The CEO of the company is Cole Austin. | Health Technology |
- Stock Market
- Insiders
- Stephan Kontos
